New drug may get heart surgery patients home days earlier
Symptom relief
Not yet recruiting
This study tests a new therapy called EA-230 to see if it helps people recover faster after coronary artery bypass surgery. In an earlier trial, those who received EA-230 spent less time in the ICU and hospital and had fewer serious problems. This larger Phase 3 trial will involv…
Phase: PHASE3 • Sponsor: EBI Anti Sepsis BV • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC